Biosortia, Inc. Email Format
Biotechnology ResearchOhio, United States2-10 Employees
Biosortia, Inc. operates in the biotechnology research space, pursuing drug discovery through its Industrial Scale Microbiome Mining (ISMM) technology. By accessing natural microbiomes, the company aims to uncover small molecules involved in cellular signaling and disease processes, creating a broad data repository that can be leveraged with advanced computational methods to prioritize potential drug candidates. This approach seeks to shorten the path from in silico predictions to preclinical testing and IND submissions, potentially accelerating development timelines for novel therapeutics. Headquartered in Columbus, Ohio, Biosortia serves biotech firms seeking to build pipeline opportunities by accessing previously hidden chemistry. The company positions itself at the intersection of natural product discovery and AI-enabled drug design, offering a platform that integrates large-scale microbiome-derived compounds with analytical methods to identify promising molecules for further optimization or derivatization.